Published July 7, 2021 | Version v1

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

  • 1. Saarland University, Department of Transplant and Infection Immunology
  • 2. Saarland University, Department of Internal Medicine IV
  • 3. Saarland University, Institute of Medical Microbiology and Hygiene

Description

Oberservational cohort study on immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost regimen (ChAdOx1 nCoV-19 followed by BNT152b2 or mRNA-1273) compared with homologous regimens (ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 or mRNA/mRNA (BNT162b2/BNT162b2 or mRNA-1273/mRNA-1273)

Files

Files (148.0 kB)

Name Size Download all
md5:f1765f5f69d6635b53f567ddb4dba1f5
148.0 kB Download